{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-23-031487","form_type":"8-K","ticker":"FEED","cik":"0001326706","company_name":"ENvue Medical, Inc.","filed_at":"2023-09-01T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.585308+00:00","generated_at":"2026-06-11T00:24:02.003236+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NanoVibronix raises ~$5M in private placement of common stock and warrants","bullets":["Offering of 2,906,977 shares (or equivalents) plus A-1 and A-2 warrants each for up to 2,906,977 shares at $1.72/unit.","A-1 warrants exercisable at $1.47/share for 5.5 years; A-2 warrants identical with 13-month term.","Gross proceeds ~$5M, net ~$4.3M after fees; closing expected Sept 1, 2023.","Proceeds for general corporate purposes including development, sales/marketing, and potential acquisitions."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-23-031487","json":"https://secwatch.observer/filing/0001493152-23-031487.json","markdown":"https://secwatch.observer/filing/0001493152-23-031487.md","text":"https://secwatch.observer/filing/0001493152-23-031487.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223031487/0001493152-23-031487-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223031487/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-11T00:24:02.003236+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"69e5e85026a0b49082dfdc6da620147888817a94","claim":"ENvue Medical, Inc. entered into Securities Purchase Agreement with institutional investor valued at 180,000 shares common stock, pre-funded warrants for 2,726,977 shares, A-1 Warrants for 2,906,977 sh (effective 2023-08-30).","evidence_excerpt":"On August 30, 2023, NanoVibronix, Inc. (the “ Company ”) entered into a securities purchase agreement (the “ Purchase Agreement ”) with an institutional investor for the issuance and sale in a private placement (the “ Private Placement ”) of 180,000 shares (the “ Common Shares ”) of common stock, par value $0.001 per share (the “ Common Stock ”) , pre-funded warrants (“ Pre-Funded Warrants ”) to purchase up to 2,726,977 shares of common stock, with an exercise price of $0.0001 per share, A-1 Warrants (the “ A-1 Warrants ”) to purchase up to 2,906,977 shares of Common Stock, with an exercise price of $1.47 per share, and A-2 Warrants (the “ A-2 Warrants ” and together with the A-1 Warrants, the “ Warrants” ) to purchase up to 2,906,977 shares of Common Stock with an exercise price of $1.47 per share.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1326706/000149315223031487/0001493152-23-031487-index.htm","confidence":0.95,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"institutional investor"},{"label":"Value","value":"180,000 shares common stock, pre-funded warrants for 2,726,977 shares, A-1 Warrants for 2,906,977 sh"},{"label":"Effective","value":"2023-08-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}